SEC Form 4 · Updated Daily
AIM
— AIM IMMUNOTECH INC. OwnershipInsider and institutional ownership derived from SEC Form 4 filings. Click any owner to see their holdings across every company they’ve filed on, and how their position has changed over time.
Current Reporting Owners
| Owner | Role | Shares Owned | As Of | Last Activity |
|---|---|---|---|---|
| KELLNER TED D | Director | 1,969,504 | 2025-04-11 | P |
| MITCHELL WILLIAM M | Director | 521,723 | 2025-04-11 | P |
| Rodino Peter W III | Officer | 401,762 | 2025-04-04 | P |
| BRYAN NANCY | Director | 291,882 | 2025-03-14 | A |
| Equels Thomas K | Director · Officer | 63,922 | 2026-03-12 | C |
| CHEMEROW DAVID I. | Director | 28,441 | 2026-03-12 | C |
Recent Filings
| Date | Owner | Activity | Shares | Price | Owned After |
|---|---|---|---|---|---|
| 2026-03-12 | CHEMEROW DAVID I. | Conversion (derivative) | 25 | $0.00 | 0 |
| 2026-03-12 | CHEMEROW DAVID I. | Conversion | 25,000 | $0.00 | 28,441 |
| 2026-03-12 | Equels Thomas K | Conversion (derivative) | 25 | $0.00 | 0 |
| 2026-03-12 | Equels Thomas K | Conversion | 25,000 | $0.00 | 63,922 |
| 2026-03-06 | CHEMEROW DAVID I. | J (derivative) | 50,000 | $0.00 | 50,000 |
| 2026-03-06 | CHEMEROW DAVID I. | J (derivative) | 25 | $25000.00 | 25 |
| 2026-03-06 | Equels Thomas K | J (derivative) | 50,000 | $0.00 | 50,000 |
| 2026-03-06 | Equels Thomas K | J (derivative) | 25 | $25000.00 | 25 |
| 2026-02-05 | CHEMEROW DAVID I. | Grant / award | 2,800 | $1.23 | 3,441 |
| 2025-06-13 | Equels Thomas K | Open-market buy | 107 | $7.70 | 38,885 |
| 2025-06-12 | Equels Thomas K | Open-market buy | 103 | $8.70 | 38,675 |
| 2025-04-11 | KELLNER TED D | Open-market buy | 1,968,504 | $0.03 | 1,969,504 |
| 2025-04-11 | Equels Thomas K | Open-market buy | 1,968,504 | $0.03 | 3,867,533 |
| 2025-04-11 | MITCHELL WILLIAM M | Open-market buy | 196,851 | $0.03 | 521,723 |
| 2025-04-04 | Rodino Peter W III | Open-market buy | 500 | $0.09 | 401,762 |
| 2025-04-04 | Equels Thomas K | Open-market buy | 41,000 | $0.06 | 1,899,029 |
| 2025-03-14 | CHEMEROW DAVID I. | Grant / award | 44,899 | $0.12 | 64,189 |
| 2025-03-14 | BRYAN NANCY | Grant / award | 44,899 | $0.12 | 291,882 |
| 2025-03-14 | MITCHELL WILLIAM M | Grant / award | 44,899 | $0.12 | 324,872 |
| 2025-03-05 | Equels Thomas K | Open-market buy | 50,000 | $0.13 | 1,858,029 |
| 2025-03-04 | Equels Thomas K | Open-market buy | 83,334 | $0.12 | 1,764,029 |
| 2025-03-04 | Equels Thomas K | Open-market buy | 44,000 | $0.12 | 1,808,029 |
| 2025-02-28 | BRYAN NANCY | Grant / award | 38,580 | $0.14 | 246,983 |
| 2025-02-28 | MITCHELL WILLIAM M | Grant / award | 38,580 | $0.14 | 279,973 |
| 2025-02-28 | CHEMEROW DAVID I. | Grant / award | 19,290 | $0.14 | 19,290 |
| 2025-02-14 | BRYAN NANCY | Grant / award | 43,330 | $0.12 | 208,403 |
| 2025-02-14 | MITCHELL WILLIAM M | Grant / award | 43,330 | $0.12 | 241,393 |
| 2025-02-14 | MITCHELL WILLIAM M | Grant / award | 43,330 | $0.12 | 241,393 |
| 2025-01-31 | BRYAN NANCY | Grant / award | 25,797 | $0.20 | 165,073 |
| 2025-01-31 | MITCHELL WILLIAM M | Grant / award | 25,797 | $0.20 | 198,063 |
| 2025-01-31 | MITCHELL WILLIAM M | Grant / award | 25,797 | $0.20 | 198,063 |
| 2025-01-15 | MITCHELL WILLIAM M | Grant / award | 27,412 | $0.19 | 172,266 |
| 2024-11-21 | Equels Thomas K | Open-market buy | 20,000 | $0.21 | 1,657,968 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.